These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 16092968

  • 1. Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients.
    Nayak SB, Bhaktha G.
    Lipids Health Dis; 2005 Aug 10; 4():15. PubMed ID: 16092968
    [Abstract] [Full Text] [Related]

  • 2. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH, EURODIAB IDDM Complications Study Group.
    Diabetes Care; 2001 Feb 10; 24(2):316-22. PubMed ID: 11213885
    [Abstract] [Full Text] [Related]

  • 3. Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy.
    Shivananda Nayak B, Duncan H, Lalloo S, Maraj K, Matmungal V, Matthews F, Prajapati B, Samuel R, Sylvester P.
    Vasc Health Risk Manag; 2008 Feb 10; 4(1):243-7. PubMed ID: 18629366
    [Abstract] [Full Text] [Related]

  • 4. Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.
    Abdella N, Akanji AO, Mojiminiyi OA, Al Assoussi A, Moussa M.
    Diabetes Res Clin Pract; 2000 Sep 10; 50(1):65-72. PubMed ID: 10936670
    [Abstract] [Full Text] [Related]

  • 5. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
    Shahid SM, Nawab SN, Shaikh R, Mahboob T.
    Pak J Pharm Sci; 2012 Jan 10; 25(1):123-9. PubMed ID: 22186319
    [Abstract] [Full Text] [Related]

  • 6. Relationship between inflammatory markers, metabolic and anthropometric variables in the Caribbean type 2 diabetic patients with and without microvascular complications.
    Nayak BS, Roberts L.
    J Inflamm (Lond); 2006 Dec 22; 3():17. PubMed ID: 17187674
    [Abstract] [Full Text] [Related]

  • 7. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
    Chen J, Gall MA, Yokoyama H, Jensen JS, Deckert M, Parving HH.
    Diabetes Care; 1996 Feb 22; 19(2):130-4. PubMed ID: 8718432
    [Abstract] [Full Text] [Related]

  • 8. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
    Yokoyama H, Jensen JS, Jensen T, Deckert T.
    J Intern Med; 1995 May 22; 237(5):519-23. PubMed ID: 7738493
    [Abstract] [Full Text] [Related]

  • 9. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
    Khan S, Qayyum S, Khan MNA.
    J Pak Med Assoc; 2024 May 22; 74(5):862-867. PubMed ID: 38783431
    [Abstract] [Full Text] [Related]

  • 10. Lack of association between serum sialic acid levels and retinopathy in Type 2 diabetic patients.
    Deepa R, Rema M, Mohan V.
    Diabetes Res Clin Pract; 1998 Sep 22; 41(3):165-9. PubMed ID: 9829344
    [Abstract] [Full Text] [Related]

  • 11. Relationship between serum nitric oxide and sialic acid in coexisted diabetes, hypertension and nephropathy.
    Shahid SM, Jawed M, Mahboob T.
    Pak J Pharm Sci; 2013 May 22; 26(3):593-7. PubMed ID: 23625435
    [Abstract] [Full Text] [Related]

  • 12. Ethnic differences in correlates of microalbuminuria in NIDDM. The role of the acute-phase response.
    Islam N, Kazmi F, Chusney GD, Mattock MB, Zaini A, Pickup JC.
    Diabetes Care; 1998 Mar 22; 21(3):385-8. PubMed ID: 9540020
    [Abstract] [Full Text] [Related]

  • 13. Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control.
    Reverter JL, Sentí M, Rubiés-Prat J, Lucas A, Salinas I, Pizarro E, Pedro-Botet J, Romero R, Sanmartí A.
    Diabetes Care; 1994 Mar 22; 17(3):189-94. PubMed ID: 8174446
    [Abstract] [Full Text] [Related]

  • 14. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy.
    Crook MA, Tutt P, Pickup JC.
    Diabetes Care; 1993 Jan 22; 16(1):57-60. PubMed ID: 8422833
    [Abstract] [Full Text] [Related]

  • 15. Serum sialic acid in young type-1 diabetic patients.
    Crook M, Cartwright K, Lumb P, Worsley A.
    Diabetes Res Clin Pract; 2000 Feb 22; 47(2):119-22. PubMed ID: 10670911
    [Abstract] [Full Text] [Related]

  • 16. Monitoring Diabetic Nephropathy by Circulating Gangliosides.
    Ene CD, Penescu M, Anghel A, Neagu M, Budu V, Nicolae I.
    J Immunoassay Immunochem; 2016 Feb 22; 37(1):68-79. PubMed ID: 26359623
    [Abstract] [Full Text] [Related]

  • 17. Significance of serum and urine neuraminidase activity and serum and urine level of sialic acid in diabetic nephropathy.
    Roozbeh J, Merat A, Bodagkhan F, Afshariani R, Yarmohammadi H.
    Int Urol Nephrol; 2011 Dec 22; 43(4):1143-8. PubMed ID: 21207147
    [Abstract] [Full Text] [Related]

  • 18. [Serum levels of sialic acid in patients with type 1 diabetes mellitus in relation to the incidence of late complications].
    Spunda J, Neumann M, Bartásková D, Kvapil M.
    Cas Lek Cesk; 1996 Nov 20; 135(22):723-5. PubMed ID: 8998824
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5.
    Pradeepa R, Anjana RM, Unnikrishnan R, Ganesan A, Mohan V, Rema M.
    Diabetes Technol Ther; 2010 Oct 20; 12(10):755-61. PubMed ID: 20818974
    [Abstract] [Full Text] [Related]

  • 20. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants.
    Idowu AA, Ajose AO, Adedeji AT, Adegoke AO, Jimoh KA.
    Ghana Med J; 2017 Jun 20; 51(2):56-63. PubMed ID: 28955101
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.